The management of orthostatic hypotension in Parkinson's disease

47Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.

Abstract

Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson's disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD. © 2013 Sánchez-Ferro, Benito-León and Gómez-Esteban.

Cite

CITATION STYLE

APA

Sánchez-Ferro, varo, Benito-León, J., & Gómez-Esteban, J. C. (2013). The management of orthostatic hypotension in Parkinson’s disease. Frontiers in Neurology, 4 JUN. https://doi.org/10.3389/fneur.2013.00064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free